Bicara Therapeutics Inc. Common Stock
USD20.00
+0.36 (+1.83%)
CEO
Claire Mazumdar Clemon
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.63
Prev. Close
$19.64
Day Low
$19.09
Day High
$20.26
52W Low
$8.48
52W High
$24.25
Market Cap
$1.10B
Volume
0.55M
| 9,200 |
| $20.42 |
| 26 May 2026 | Hyep Ivan | Chief Financial Officer | M-Exempt | Disposed | 9,200 | $3.79 |
| 20 May 2026 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | Acquired | 15,000 | $3.79 |
| 20 May 2026 | Mazumdar Claire | director, officer: Chief Executive Officer | S-Sale | Disposed | 12,022 | $19.96 |
| 20 May 2026 | Mazumdar Claire | director, officer: Chief Executive Officer | S-Sale | Disposed | 2,978 | $20.35 |
| 20 May 2026 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | Disposed | 15,000 | $3.79 |
| 18 May 2026 | Cohlhepp Ryan | director, officer: President and COO | M-Exempt | Acquired | 8,000 | $3.79 |
| 18 May 2026 | Cohlhepp Ryan | director, officer: President and COO | S-Sale | Disposed | 8,000 | $20.29 |
| 18 May 2026 | Cohlhepp Ryan | director, officer: President and COO | S-Sale | Disposed | 4,500 | $20.29 |